Thalassemia Treatment Market 2018-2024
18-Jul-2018 | Number of pages: 178 | Report Id: BMRC PH 131 | Report Format: | Status: Upcoming

Global Thalassemia Treatment Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2018-2024

Global Thalassemia Treatment Market 2018-2024

Brandessence Market Research is working on a new report titleGlobal Thalassemia Treatment Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2018-2024″. Rise in number of altered Thalassemia genes, increase in awareness about the disease and high adoption of chelation therapy & blood transfusion for treatment by doctors as well as patients arelikely to enhance the growth of Global Thalassemia Treatment Market.

Scope of Global Thalassemia Treatment Market Reports –

 Thalassemia is aninherited blood disorder in which the body makes an abnormal form of hemoglobin.People having Thalassemia disease are unable to make sufficient hemoglobin which causes severe anemic conditions.Hemoglobin is found in red blood cells and transports oxygen to all parts of the body. When there is insufficient hemoglobin in the red blood cells, oxygen cannot get to all parts of the body. Organs demand oxygen and are unable to function properly.There are two primary types of Thalassemia disease such as Alpha Thalassemia disease and Beta Thalassemia disease.Alpha Thalassemia results in a formation of additional beta globins, which leads to the formation of beta-globin tetramers (β4) called Hemoglobin H.

Beta Thalassemia causesadditionalformation of alpha globins, which develops alpha globin tetramers (α4) that store in the erythroblast (immature red blood cell).Thalassemia is caused by mutations in the DNA of cells that make hemoglobin.

Factors that increase risk of Thalassemia include Family history of thalassemia and certain ancestry.Possible complications of Thalassemia includeIron overload, Infections, Bone deformities, splenomegaly, slowed growth rate of child and Heart problems.

Thalassemia signs and symptoms include Fatigue, Weakness, Pale or yellowish skin, Facial bone deformities, slow growth, abdominal swelling, Dark urine, chest pain,cold hands and feet, poor feeding, greater susceptibility to infections. Diagnosis of Thalassemia includesa complete blood count (CBC), a reticulocyte count,Iron count, Genetic testing and prenatal testing. Treatment of Thalassemia depends on the type and severity of Thalassemia such as Blood transfusions, Bone marrow or stem cell transplant, Surgery and Gene therapy.

Global Thalassemia Treatment Market has been segmented on the basis ofType of Treatment, Diagnosis, End usersand Geography. On the basis of Type of TreatmentGlobal Thalassemia Treatment Market is classified into Blood Transfusion, Chelating Therapy, Bone Marrow Transplant, Stem Cell Transplant, Surgery, Gene Therapy and Others.On the basis of DiagnosisGlobal Thalassemia Treatment Market is classified into Perinatal Testing, Prenatal Testing, Pre-Implantation and Other.On the basis of the End user the Global Thalassemia Treatment Market is classified into Hospitals, Biotechnological Laboratories, Diagnostic Laboratories, Educational Research Institutes, Pharmaceutical Industries and others.

The regions covered in Global Thalassemia Treatment Market report are North America, Europe, Asia-Pacific and Rest of the World. On the basis of country level, Global Melanoma Drug Market sub divided in to U.S., Mexico, Canada, U.K., France, Germany, Italy, China, Japan, India, South East Asia, GCC, Africa, etc.

Key Players for Global Thalassemia Treatment Market Reports –

Global Thalassemia Treatment Market reports cover prominent players like Bluebird bio Inc., Acceleron Pharma Inc., Novartis AG, Celgene Corporation, Shire plc, Bellicum Pharmaceuticals, GlaxoSmithKline Plc, Celgene,Lonza group, Alnylam Pharmaceuticals Inc., Calimmune Inc., CRISPR Therapeutics, Editas Medicine Inc., Errant Gene Therapeutics LLC, Gamida Cell Ltd, Gilead Sciences Inc., Incyte Corp, Ionis Pharmaceuticals Inc., IRBM Science Park SpA, Johnson & Johnson, Kiadis Pharma NV, La Jolla Pharmaceutical Company, Merck & Co Inc., PharmaEssentia Corp, Protagonist Therapeutics Inc., Sangamo Therapeutics Inc., Zydus Cadila Healthcare Ltd, Genorama Ltd, HiMedia Laboratories, DiagCor Bioscience Inc. Ltd and Tosoh Bioscience Inc.

Global Thalassemia Treatment Market Dynamics –

Increase in awareness about the disease and technological expansions are likely to raise the adoption of gene therapies. Also Rising Prevalence of Thalassemia, Increase in Pharmaceutical R&D Spending, Increasing Spending on Stem Cell Research, Rising Healthcare Expenditure and Rising Asian Population will boost theGlobal Thalassemia Treatment Market. Treatment of Thalassemia is mostly restricted to regular blood transfusions and iron chelation therapy.Moreover, High operation cost of sophisticated clinical and preclinical imaging systems, High cost of maintenance andless life span of accessoriesalso restraining theGlobal Thalassemia Treatment Market.Yearlyspending for treatment of Thalassemia ranged from $ 108 to 432, depending on type of treatment with average cost per blood transfusion was $ 5.2±2.2. Average 18.5%±14.3 of the total annual income was spent on the treatment for Thalassemia. Drugs prescribed for Thalassemia mostly cures symptoms and side effects such as anemia, iron overload, slow growth of children and vitamin deficiency.Occurrence of Thalassemia is reported to increase steadily over the years across different regions. This can be due to population migration, intermarriages, genetic as well as environmental factors prompting the condition and its implications.Systematic Drugs under Pipeline, Rising Scope for Gene Therapy and increasing awareness towards Thalassemia are some opportunities in the forecast period for theGlobal Thalassemia Treatment Market.

Global Thalassemia Treatment MarketRegional Analysis –

North America have largest share ofGlobal Thalassemia Treatment Market. It is mainly driven by quickly increasing immigrant population from tropical regions, rising number of population with Thalassemia carrier gene and rise in birth rates due to variation of genes among the population in the U.S.There are some prenatal tests available on the market to determine the possibility of alpha thalassemia including both invasive and non-invasive technique.

The alpha thalassemia testing market has aemergent trend in the countries with traditional groups like Mediterranean countries, African countries and few countries in Asia Pacific. Furthermore, in Asia Pacific region the growth in similar community marriage practices and high fertility ratewith alpha thalassemia patients have been detected. This is expected to raiseacceptance of blood transfusion and chelation therapy treatments during the forecast period.A latestimprovement in the testing of alpha Thalassemia may determine the risk of the disease by in vitro examination of the embryo. While there are various such tests available in theGlobal Thalassemia Treatment Market but lack of awareness leads to the neglect and delayed diagnosis of the diseased state.

Most frequently prone area for alpha thalassemia is Mediterranean countries, African countries, and Southeast Asian countries. Thalassemia trait practically affects 6% to 35% of the population in these ethnic groups. Middle East & Africa is likely to be the fastest risingGlobal Thalassemia Treatment Market during the forecast period.

Key Benefits for Global Thalassemia Treatment Market Reports –

  • Global Thalassemia Treatment Market report covers in depth historical and forecast analysis.
  • Global Thalassemia Treatment Market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Global market sale (K Units), Global market Drivers, Market Restraints, Market opportunities, Competitive Analysis, Regional and Country Level.
  • Global Thalassemia Treatment Market report helps to identify opportunities in market place.
  • Global Thalassemia Treatment Market report covers extensive analysis of emerging trends and competitive landscape.

Global Thalassemia Treatment Market Segmentation

 Global Thalassemia Treatment Market: By Type of Treatment Analysis

  • Blood Transfusion
  • Chelating Therapy
  • Bone Marrow Transplant
  • Stem Cell Transplant
  • Surgery
  • Gene Therapy
  • Other

Global Thalassemia Treatment Market: By Diagnosis Analysis

  • Perinatal Testing
  • Prenatal Testing
  • Pre-Implantation
  • Other

Global Thalassemia Treatment Market: By End user Analysis

  • Hospitals
  • Biotechnological Laboratories
  • Diagnostic Laboratories
  • Educational Research Institutes
  • Pharmaceutical Industries
  • Other

Global Thalassemia Treatment Market: By Regional & Country Analysis

  • North America
    • U.S.
    • Mexico
    • Canada
  • Europe
    • UK
    • France
    • Germany
    • Italy
  • Asia Pacific
    • China
    • Japan
    • India
    • Southeast Asia
  • Latin America
    • Brazil
  • The Middle East and Africa
    • GCC
    • Africa
    • Rest of Middle East and Africa

 

 

 

 

Table of Content

  1. Chapter – Report Methodology
    • Research Process
    • Primary Research
    • Secondary Research
    • Market Size Estimates
    • Data Triangulation
    • Forecast Model
    • USP’s of Report
    • Report Description
  2. Chapter – Global Thalassemia Treatment Market Overview: Qualitative Analysis
    • Market Introduction
    • Executive Summary
    • Global Thalassemia Treatment Market Classification
    • Market Drivers
    • Market Restraints
    • Market Opportunity
    • Global Thalassemia Treatment Market: Trends
    • Porter’s Five Forces Analysis
      • Bargaining Power of Suppliers
      • Bargaining Power of Consumers
      • Threat of New Entrants
      • Threat of Substitute Product and Services
      • Competitive Rivalry within the Industry
    • Market Attractiveness Analysis
      • Market Attractiveness Analysis by Segmentation
      • Market Attractiveness Analysis by Region
  1. Chapter – Global Thalassemia Treatment Market Overview: Quantitative Analysis
    • Global Thalassemia Treatment Market Production (K Unit), Market Share (%) and Growth Rate (%), 2014- 2024
    • Global Thalassemia Treatment Market Consumption (K Unit), Market Share ( %) and Growth Rate, 2014- 2024
    • Global Thalassemia Treatment Market Revenue (USD Million), Market Share (%) and Growth Rate (%), 2014- 2024
  2. Chapter –Global Thalassemia Treatment Market: by Type of Treatment
  3. Chapter –Global Thalassemia Treatment Market: by Diagnosis
  4. Chapter –Global Thalassemia Treatment Market: by End user
  5. Chapter –Global Thalassemia Treatment Market: by Manufacturer
    • Global Thalassemia Treatment Market(USD Million), by Manufacturer, 2014 – 2024
    • Global Thalassemia Treatment Market Production (K Unit), by Manufacturer, 2014 – 2024
    • Global Thalassemia Treatment Market Consumption (K Unit), Manufacturer, 2014 – 2024
    • Global Thalassemia Treatment Market Share (%), by Manufacturer, 2017
    • Global Thalassemia Treatment Market Price (USD/Unit), by Manufacturer, 2014 – 2024
    • Global Thalassemia Treatment Market Revenue Growth Rate (%), by Manufacturer, 2014 – 2024
    • Merger & Acquisition
    • Collaborations and Partnership
    • New Product Launch
  6. Chapter -Global Thalassemia Treatment Market: Regional Analysis
    • North America
    • North America Global Thalassemia Treatment Market Revenue (USD Million) and Growth Rate (%), 2014 – 2024.
    • North America Global Thalassemia Treatment Market Revenue (USD Million) By Country, 2014 – 2024.
    • North America Global Thalassemia Treatment Market Revenue Market Share (%) By Country, 2014 – 2024.
    • North America Global Thalassemia Treatment Market Revenue (USD Million), Market Share (%) and Growth Rate, By Market Segmentation, 2014 – 2024.
    • North America Global Thalassemia Treatment Market Revenue (USD Million), Market Share (%) and Growth Rate, By Market Segmentation, 2014 – 2024.
    • North AmericaGlobal Thalassemia Treatment Market Revenue (USD Million), Market Share (%) and Growth Rate, By Market Segmentation, 2014 – 2024.
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East & Africa
  7. Chapter – Company Profiles

8.1.1. Acceleron Pharma Inc.

8.1.2.Overview

8.1.3.Financials

  • Product portfolio
  • Global Thalassemia Treatment Market Revenue (USD Million), Production (K Unit), Consumption (K Unit) and Market Share (%), 2014 – 2017
  • Global Thalassemia Treatment Market Share (%), 2014 – 2017
  • Alnylam Pharmaceuticals Inc.
  • Bellicum Pharmaceuticals
  • Bluebird bio Inc.
  • Calimmune Inc.
  • Celgene Corporation
  • CRISPR Therapeutics
  • DiagCor Bioscience Inc. Ltd
  • Editas Medicine Inc.
  • Errant Gene Therapeutics LLC
  • Gamida Cell Ltd
  • Genorama Ltd
  • Gilead Sciences Inc.
  • GlaxoSmithKline Plc
  • HiMedia Laboratories
  • Incyte Corp
  • Ionis Pharmaceuticals Inc.
  • IRBM Science Park SpA
  • Johnson & Johnson
  • Kiadis Pharma NV
  • La Jolla Pharmaceutical Company
  • Lonza group
  • Merck & Co Inc.
  • Novartis AG
  • PharmaEssentia Corp
  • Protagonist Therapeutics Inc.
  • Sangamo Therapeutics Inc.
  • Shire plc
  • Tosoh Bioscience Inc.
  • Zydus Cadila Healthcare Ltd
  • Others
  1. Chapter – Market Research and Findings

 

 

Global Thalassemia Treatment Market 2018-2024

Our 178 pages report provides 78 tables, 70 charts and graphs. The report covers historical and forecast data of North America, Europe, Asia Pacific, Latin America and Middle East & Africa. Our study focuses on the most lucrative areas in the industry and the future market prospects. Market covers financial results, trends, opportunities and revenue predictions from 2018 to 2024. Significant rise in research and development activities by leading vendors.

Why you should buy this report:

  • To receive a comprehensive analysis of the prospects for Global Thalassemia Treatment Market
  • To receive forecasts of Global Thalassemia Treatment Market Sales in leading country markets from 2018-2024, including leading and emerging country from developed and developing regions 
  • To discover the views of experts in theGlobal Thalassemia Treatment Market sector
  • To determine the forces and factor that influences the market forGlobal Thalassemia Treatment Market: drivers, restraints, opportunities and threats
  • To find out where the Global Thalassemia Treatment Market is heading – both technologically and commercially from 2018-2024
  • Report Include tables of contract/projects and its value and description by  region and Country

Global Thalassemia Treatment Market: By Region Analysis

  2017

(USD Million)

2024

(USD Million)

2017 Market Share (%) CAGR (%)

2018-2024

Consumption

(K Unit)

Global XX XX XX XX XX
North America XX XX XX XX XX
Europe XX XX XX XX XX
Asia Pacific XX XX XX XX XX
Latin America XX XX XX XX XX
Middle East & Africa XX XX XX XX XX
Global XX XX XX XX XX

Source: Brandessence Market Research, 2018

Global Thalassemia Treatment Market: ByType of Treatment Analysis

  2017

(USD Million)

2024

(USD Million)

2017 Market Share (%) CAGR (%)

2018-2024

Consumption

(K Unit)

Blood Transfusion XX XX XX XX XX
Chelating Therapy XX XX XX XX XX
Bone Marrow Transplant XX XX XX XX XX
Stem Cell Transplant XX XX XX XX XX
Surgery XX XX XX XX XX
Gene Therapy XX XX XX XX XX
Others XX XX XX XX XX

Source: Brandessence Market Research, 2018

Global Thalassemia Treatment Market: By Diagnosis Analysis

  2017

(USD Million)

2024

(USD Million)

2017 Market Share (%) CAGR (%)

2018-2024

Consumption

(K Unit)

Perinatal Testing XX XX XX XX XX
Prenatal Testing XX XX XX XX XX
Pre-Implantation XX XX XX XX XX
Other XX XX XX XX XX

Source: Brandessence Market Research, 2018

Global Thalassemia Treatment Market: By End user Analysis

  2017

(USD Million)

2024

(USD Million)

2017 Market Share (%) CAGR (%)

2018-2024

Consumption

(K Unit)

Hospitals XX XX XX XX XX
Biotechnological Laboratories XX XX XX XX XX
Diagnostic Laboratories XX XX XX XX XX
Educational Research Institutes XX XX XX XX XX
Pharmaceutical Industries XX XX XX XX XX
Others XX XX XX XX XX

Source: Brandessence Market Research, 2018

Why You Must Buy This Report:

This report features news, insights, the latest developments and an in depth survey ofGlobal Thalassemia Treatment Market with up-to-date analysis as well as tables, graphs and charts. This report is a vital addition to gaining an understanding of this market sector and will give your company ‘the edge’ on your competitors.

Email me today to order this report or to ask for assistance. I look forward to receiving your email on sales@brandessenceresearch.com

 

Companies Mentioned in This Report,

  • Acceleron Pharma Inc.
  • Alnylam Pharmaceuticals Inc.
  • Bellicum Pharmaceuticals
  • Bluebird bio Inc.
  • Calimmune Inc.
  • Celgene Corporation
  • CRISPR Therapeutics
  • DiagCor Bioscience Inc. Ltd
  • Editas Medicine Inc.
  • Errant Gene Therapeutics LLC
  • Gamida Cell Ltd
  • Genorama Ltd
  • Gilead Sciences Inc.
  • GlaxoSmithKline Plc
  • HiMedia Laboratories
  • Incyte Corp
  • Ionis Pharmaceuticals Inc.
  • IRBM Science Park SpA
  • Johnson & Johnson
  • Kiadis Pharma NV
  • La Jolla Pharmaceutical Company
  • Lonza group
  • Merck & Co Inc.
  • Novartis AG
  • PharmaEssentia Corp
  • Protagonist Therapeutics Inc.
  • Sangamo Therapeutics Inc.
  • Shire plc
  • Tosoh Bioscience Inc.
  • Zydus Cadila Healthcare Ltd
  • Others

 

 

 

  • Acceleron Pharma Inc.
  • Alnylam Pharmaceuticals Inc.
  • Bellicum Pharmaceuticals
  • Bluebird bio Inc.
  • Calimmune Inc.
  • Celgene Corporation
  • CRISPR Therapeutics
  • DiagCor Bioscience Inc. Ltd
  • Editas Medicine Inc.
  • Errant Gene Therapeutics LLC
  • Gamida Cell Ltd
  • Genorama Ltd
  • Gilead Sciences Inc.
  • GlaxoSmithKline Plc
  • HiMedia Laboratories
  • Incyte Corp
  • Ionis Pharmaceuticals Inc.
  • IRBM Science Park SpA
  • Johnson & Johnson
  • Kiadis Pharma NV
  • La Jolla Pharmaceutical Company
  • Lonza group
  • Merck & Co Inc.
  • Novartis AG
  • PharmaEssentia Corp
  • Protagonist Therapeutics Inc.
  • Sangamo Therapeutics Inc.
  • Shire plc
  • Tosoh Bioscience Inc.
  • Zydus Cadila Healthcare Ltd
  • Others